Mirae Asset Capital - aVenture Asset Manager Research
Mirae Asset Capital
Operating Status: Operating
Seoul-based South Korean firm specializing in customized investment financing solutions.
Location
Seoul, KR
Founded
1997
Mirae Asset Capital is a Seoul-based South Korean investment firm specializing in customized financing solutions. The firm demonstrates a diverse investment strategy, participating in funding rounds from Seed to Series E, with a particular focus on Series B and C investments. Their portfolio spans various sectors including biotechnology, healthcare, artificial intelligence, and technology.
Notable portfolio companies include Apeel Sciences, Insilico Medicine, and Valo Health in the biotech sector, as well as AmazeVR and Syntiant in technology. Mirae Asset Capital's investments range from early-stage startups to more established companies, with total raised amounts for portfolio companies varying widely from $16 million to over $250 million. The firm's global reach is evident in its investments across different geographies and industries.
Mirae Asset Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages